Targeted Synthesis and Study of Anti-tyrosinase Activity of 2-Substituted Tetrahydrobenzo[4,5]Thieno[2,3-d]Pyrimidine-4(3H)-One

Background The high prevalence of skin hyperpigmentation makes it necessary to search for remedies that could hinder this process. Among such substances, tyrosinase inhibitors can be distinguished, which may be pyrimidine derivatives. Objectives This study aimed to investigate new compounds with anti-tyrosinase activity in 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one by an in vitro analysis and investigating their molecular docking. Methods A molecular docking was performed using AutoDock 4.0 with the 3-dimensional structure of tyrosinase of the fungus Agaricus bisporus from the Protein Data Bank (PDB; rcsb.org) with identification number 2Y9X. A synthesis of 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one was carried out during the heterocyclization reaction of azomethine derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide in glacial acetic acid with the addition of dimethyl sulfoxide. Tyrosinase activity was determined in vitro by the spectrophotometric method. Results Molecular docking data suggest the feasibility of synthesizing 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one as possible tyrosinase inhibitors. Of particular interest are compounds with hydroxy groups in the radical. Next, pharmacological screening showed that the leading compound is 4g. It is likely that metal–ligand interactions are the main interactions in the active site of tyrosinase because kojic acid, hydroquinone, and lactic acid (reference compounds), as well as compounds with only hydroxy groups in phenyl substituents (4b, 4c, and 4g), have the greatest anti-tyrosinase activity. Conclusions As a result of molecular docking studies, the feasibility of synthesizing 2-substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one as potential tyrosinase inhibitors was justified. 2-Substituted tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine-4(3H)-one was obtained using new synthesis conditions. The leading compound is 4g containing a fragment of 2,4-dihydroxybenzene.

[1]  Fanzhu Li,et al.  Construction of a Pyrimidine Framework through [3 + 2 + 1] Annulation of Amidines, Ketones, and N,N-Dimethylaminoethanol as One Carbon Donor. , 2021, The Journal of organic chemistry.

[2]  J. Legac,et al.  Design, synthesis, crystal structure and anti-plasmodial evaluation of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives. , 2021, RSC medicinal chemistry.

[3]  I. Kodonidi,et al.  Targeted Synthesis and Analysis of Biologically Active Azomethine Derivatives of 2-amino-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide , 2021, Drug development & registration.

[4]  S. Prajapati,et al.  Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation. , 2021, European journal of medicinal chemistry.

[5]  Nadia Ali Ahmed Elkanzi Synthesis and Biological Activities of Some Pyrimidine Derivatives: A Review , 2020 .

[6]  M. Furue,et al.  Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands , 2019, International journal of environmental research and public health.

[7]  G. Abuo-Rahma,et al.  Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors. , 2019, Bioorganic chemistry.

[8]  R. G. Giménez García,et al.  Drug-Induced Hyperpigmentation: Review and Case Series , 2019, The Journal of the American Board of Family Medicine.

[9]  S. Boddu,et al.  Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells , 2019, Cancers.

[10]  M. Saeedi,et al.  Kojic acid applications in cosmetic and pharmaceutical preparations. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  Mahmud Tareq Hassan Khan,et al.  A comprehensive review on tyrosinase inhibitors , 2019, Journal of enzyme inhibition and medicinal chemistry.

[12]  M. Ghashang,et al.  ZnO-CeO2 nanocomposite: efficient catalyst for the preparation of thieno[2,3-d]pyrimidin-4(3H)-one derivatives , 2018 .

[13]  M. Mahmoud,et al.  Synthesis and antitumor evaluation of novel tetrahydrobenzo[4′,5′]thieno[3′,2′:5,6]pyrimido[1,2-b]isoquinoline derivatives , 2018 .

[14]  L. Ouyang,et al.  Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer. , 2017, Journal of medicinal chemistry.

[15]  Di Chen,et al.  Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents , 2017, Molecules.

[16]  R. Robey,et al.  Thienopyrimidine derivatives exert their anticancer efficacy via apoptosis induction, oxidative stress and mitotic catastrophe. , 2017, European journal of medicinal chemistry.

[17]  K. França,et al.  Psychosocial impact of acne and postinflammatory hyperpigmentation* , 2017, Anais brasileiros de dermatologia.

[18]  V. Prachayasittikul,et al.  Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents. , 2017, Mini reviews in medicinal chemistry.

[19]  H. Marona,et al.  Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds. , 2016, Current medicinal chemistry.

[20]  Ling Yao,et al.  Indicators for Environment Health Risk Assessment in the Jiangsu Province of China , 2015, International journal of environmental research and public health.

[21]  J. Levitt,et al.  Hydroquinone therapy for post-inflammatory hyperpigmentation secondary to acne: not just prescribable by dermatologists. , 2012, Acta dermato-venereologica.

[22]  N. Lall,et al.  Melanogenesis and Antityrosinase Activity of Selected South African Plants , 2012, Evidence-based complementary and alternative medicine : eCAM.

[23]  B. Dijkstra,et al.  Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone. , 2011, Biochemistry.

[24]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[25]  S. Desenko,et al.  Three possible products from the reactions of gewald's amide with aromatic aldehydes , 2008 .

[26]  Indu Bala Jaganath,et al.  Phenols, Polyphenols and Tannins: An Overview , 2007 .

[27]  A. Rahim,et al.  Synthesis and antimicrobial evaluation of some new thienopyrimidine derivatives. , 2006, Acta pharmaceutica.

[28]  D. Powell,et al.  Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs. , 2005, Bioorganic & medicinal chemistry letters.

[29]  Brian J. Teppen,et al.  HyperChem, release 2: molecular modeling for the personal computer , 1992, J. Chem. Inf. Comput. Sci..

[30]  A. Agarwal,et al.  A Review on Pharmacological Aspects of Pyrimidine Derivatives , 2020 .

[31]  О. О. Новиков,et al.  СИНТЕЗ НОВЫХ N- ГИДРОКCИФЕНИЛЬНЫХ И ТОЛИЛЬНЫХ ПРОИЗВОДНЫХ ПИРИМИДИН-4(1Н)-ОНА, ОБЛАДАЮЩИХ ПРОТИВОВОСПАЛИТЕЛЬНОЙ АКТИВНОСТЬЮ , 2017 .